Interconnected Pathways and Emerging Therapies in Chronic Kidney Disease and Heart Failure: A Comprehensive Review
ESC Heart Failure · 2025
DOI: 10.1002/ehf2.15345 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Johann Bauersachs und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Heart Failure, Renal Insufficiency, Chronic, Disease Management. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Chronic kidney disease (CKD) and chronic heart failure (HF) frequently coexist and, when comorbid, are associated with poorer outcomes. These two diseases have common risk factors, such as diabetes, obesity and hypertension, and common pathophysiological connected mechanisms, including inflammation, endothelial dysfunction, neurohormonal activation and fibrosis. Early diagnosis and intervention are important to slow CKD progression and reduce HF events. Shared therapeutic targets for CKD and HF include the renin–angiotensin system (RAS), sodium-glucose cotransporter 2 (SGLT2), mineralocorticoid receptor (MR) and glucagon-like peptide-1 (GLP-1) receptor. For the management of CKD, current treatment guidelines recommend the use of RAS inhibitors, SGLT2 inhibitors, the nonsteroidal MR antagonist finerenone and GLP-1 receptor agonists. Challenges in the management of patients with CKD and HF include the presence of other comorbidities, leading to polypharmacy. This review highlights gaps and opportunities for improving the management of patients with CKD and chronic HF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
- Department of Cardiovascular Medicine and Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan.
- George Washington University, Washington, DC, USA.
ORCID-Profile: Johann Bauersachs
Zitieren
APA
Bauersachs, J., Kato, E. T., & Rangaswami, J. (2025). Interconnected Pathways and Emerging Therapies in Chronic Kidney Disease and Heart Failure: A Comprehensive Review. ESC Heart Failure. https://doi.org/10.1002/ehf2.15345
Vancouver
Bauersachs J, Kato ET, Rangaswami J. Interconnected Pathways and Emerging Therapies in Chronic Kidney Disease and Heart Failure: A Comprehensive Review. ESC Heart Failure. 2025. doi:10.1002/ehf2.15345
BibTeX
@article{Bauersachs2025,
author = {Bauersachs, Johann and Kato, Eri Toda and Rangaswami, Janani},
title = {Interconnected Pathways and Emerging Therapies in Chronic Kidney Disease and Heart Failure: A Comprehensive Review},
journal = {ESC Heart Failure},
year = {2025},
doi = {10.1002/ehf2.15345}
}
EUVIMED